Lifetime risk for ovarian cancers is 40–66 % and 10–20 % in BRCA1 and BRCA2 germline mutation carriers, respectively [8–11], in contrast to 1.8 % in the general population [12]. This evidence concerns the gene BRCA1 and ovarian carcinoma.